USE OF A NOVEL ALPHA-7 nAChR ANTAGONIST TO SUPPRESS PATHOGENIC SIGNAL TRANSDUCTION IN CANCER AND AIDS
申请人:PAPKE Roger L.
公开号:US20100179186A1
公开(公告)日:2010-07-15
This application provides a method for the use of select quaternary ammonium antagonists to alpha-7 nAChR for the treatment of cancer and HIV and AIDS.
该应用程序提供了一种使用选择性四价铵拮抗剂对α-7 nAChR进行治疗癌症、HIV和艾滋病的方法。
USE OF TETRAKIS-QUATERNARY AMMONIUM SALTS AS PAIN MODULATING AGENTS
申请人:HOLTMAN Joseph R.
公开号:US20100173937A1
公开(公告)日:2010-07-08
Provided are methods of modulating, treating, reversing and/or preventing pain using tetrakis quaternary ammonium compounds, especially regarding pain of central and/or peripheral origin and/or pain which is nociceptive, neuropathic, somatic, visceral, and/or inflammatory in nature.
Use of a Novel Alpha-7 Nachr Antagonist to Suppress Pathogenic Signal Transduction in Cancer and Aids
申请人:UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
公开号:US20130231366A1
公开(公告)日:2013-09-05
This application provides a method for the use of select quaternary ammonium antagonists to alpha-7 nAChR for the treatment of cancer and HIV and AIDS.
Tetrakis-quaternary ammonium salts and methods for modulating neuronal nicotinic acteylcholine receptors
申请人:Crooks Peter A.
公开号:US08629163B2
公开(公告)日:2014-01-14
Provided are tetrakis-quaternary ammonium compounds which are modulators of nicotinic acetylcholine receptors. Also provided are methods of using the compounds for modulating the function of a nicotinic acetylcholine receptor, and for the prevention and/or treatment of central nervous system disorders, substance use and/or abuse, and or gastrointestinal tract disorders.